Could this be a new weapon against antibiotic resistance?

Christian LaVallee prepares solutions for polymerase chain reaction (PCR) tests at the Health Protection Agency in north London March 9, 2011. For decades scientists have managed to develop new medicines to stay at least one step ahead of the ever-mutating enemy, bacteria. Now, though, we may be running out of road. Methicillin-resistant Staphylococcus aureus, commonly known as MRSA, alone is estimated to kill around 19,000 people every year in the United States -- far more than HIV and AIDS -- and a similar number in Europe, and other drug-resistant superbugs are spreading. Picture taken March 9, 2011.

This virus performs a neat evolutionary trick, and scientists came across in a Connecticut pond. Image: REUTERS/Suzanne Plunkett

Bill Hathaway
Associate Director Science and Medicine, Yale
Share:
The Big Picture
Explore and monitor how Innovation is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Innovation

Yale researchers were fishing for a new weapon against antibiotic resistance and found one floating in a Connecticut pond, they report May 26 in the journal Scientific Reports.

The virus called a bacteriophage, found in Dodge Pond in East Lyme, attacks a common multi-drug resistant bacterial pathogen called Pseudomonas aeruginosa, which can lethally infect people with compromised immune systems. In a neat evolutionary trick, the virus attaches to the cell membrane where bacteria pump out antibiotics, a system that had originally evolved to resist antibiotics. The presence of the virus in turn leads to evolutionary changes in the bacterial membrane that makes this pumping mechanism less efficient. This makes bacteria once more susceptible to existing antibiotics.

 Deaths from drug-resistant infections set to skyrocket
Image: Statista

“We have been looking for natural products that are useful in combating important pathogens,” said Paul Turner, professor and chair of the Department of Ecology and Evolutionary Biology. “What’s neat about this virus is it binds to something the organism needs to become pathogenic, and backs it into an evolutionary corner such that it becomes more sensitive to currently failing antibiotics.”

The virus should help preserve our limited antibiotic arsenal in combating deadly bacteria, he said.

This “phage” therapy could be used in conjunction with antibiotics to treat dangerous P. aeruginosainfections that afflict patients with severe burns, surgical wounds, cystic fibrosis, and other conditions that compromise the immune system.

Turner also noted that other phages hold promise to combat bacterial pathogens that cause economic losses in plant and animal agriculture, and those that contaminate pipes and equipment such as bioreactors in food manufacturing..

Benjamin K. Chan is lead author of the study.

The work was funded by National Science Foundation and the Project High Hopes Foundation.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

About Us

Events

Media

Partners & Members

  • Sign in
  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum